Latest California Healthline Stories
Patients flocked to researcher who ignored usual patient protections, as university claimed ignorance.
After a Kaiser Health News report on an offshore herpes vaccine trial that skirted FDA regulations, St. Kitts and Nevis officials claim they had no knowledge of the testing. An investigation is underway.
Prominent businessmen and an American university supported offshore testing of an experimental vaccine.
Among hurdles: Older adults may have multiple illnesses that could complicate research or they might be unable to manage the commute.
Innate Immunotherapeutics, whose largest shareholder is Buffalo-area Rep. Chris Collins, received FDA approval to begin U.S. trials of its drug for treating advanced multiple sclerosis.
Researchers, who detail the women’s experiences in the New England Journal of Medicine, say it exposes the need for better regulation of clinical trials.
Pricey and unproven therapies that sound too good to be true probably are.
Researchers examine the Food and Drug Administration’s “revolving door” regarding employees who worked on cancer and hematology drugs.
Some clinics on NIH’s website charge people to participate in testing of unproven treatments — and it can come as a surprise to unsuspecting patients.
California health officials are collaborating with a dozen hospitals in a first attempt to upgrade the state’s giant cancer database.